Generix SA Announces Consolidated Earnings Results for the Six Months Ended September 30, 2018; Provides Earnings Guidance for the Fiscal 2019
The Group confirms the improvement in turnover and EBITDA for the 2018/2019 fiscal year.
1st Jan change | Capi. | |
---|---|---|
+9.52% | 3,085B | |
+7.40% | 85.92B | |
+4.19% | 77.91B | |
-16.81% | 52.89B | |
+24.20% | 48.28B | |
+29.64% | 45.38B | |
-33.37% | 40.83B | |
+70.90% | 38.78B | |
+1.04% | 27.48B |